Head-To-Head Contrast: Actelis Networks (NASDAQ:ASNS) and Mirion Technologies (NYSE:MIR)

Actelis Networks (NASDAQ:ASNS) and Mirion Technologies (NYSE:MIR) are both technology companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, valuation, risk, earnings and dividends.

Earnings and Valuation

This table compares Actelis Networks and Mirion Technologies”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Actelis Networks	$3.67 million	0.39	-$8.26 million	($1.91)	-0.03
Mirion Technologies	$925.40 million	5.08	$28.80 million	$0.12	157.42

Mirion Technologies has higher revenue and earnings than Actelis Networks. Actelis Networks is trading at a lower price-to-earnings ratio than Mirion Technologies, indicating that it is currently the more affordable of the two stocks.

Institutional & Insider Ownership

12.4% of Actelis Networks shares are owned by institutional investors. Comparatively, 78.5% of Mirion Technologies shares are owned by institutional investors. 0.2% of Actelis Networks shares are owned by insiders. Comparatively, 2.2% of Mirion Technologies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Risk and Volatility

Actelis Networks has a beta of 0.66, meaning that its share price is 34% less volatile than the S&P 500. Comparatively, Mirion Technologies has a beta of 1.07, meaning that its share price is 7% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of recent ratings and price targets for Actelis Networks and Mirion Technologies, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Actelis Networks	1	1	1	0	2.00
Mirion Technologies	0	2	7	1	2.90

Mirion Technologies has a consensus target price of $24.88, indicating a potential upside of 31.68%. Given Mirion Technologies’ stronger consensus rating and higher possible upside, analysts clearly believe Mirion Technologies is more favorable than Actelis Networks.

Profitability

This table compares Actelis Networks and Mirion Technologies’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Actelis Networks	-225.03%	-290.78%	-111.82%
Mirion Technologies	2.69%	6.82%	3.62%

Summary

Mirion Technologies beats Actelis Networks on 15 of the 15 factors compared between the two stocks.

About Actelis Networks

Actelis Networks, Inc. engages in the design, development, manufacture, and marketing of cyber hardened, hybrid fiber, networking solutions for Internet of Things and telecommunication companies in North America, Europe, the Middle East, Israel, and the Asia Pacific. It provides rapid-deployment networking solutions for wide-area IoT applications, including federal, state, and local governments; intelligent traffic systems; and military, utility, rail, telecom, and campus applications. The company’s products include ethernet access devices; network aggregator switches; and Advanced MetaLIGHT/ Gigaline element management systems software, which enables remote management, monitoring, maintenance, and configuration of the installed equipment in the network. It also offers dynamic spectral software; and access broadband equipment. It serves offers its products through system integrators, distributors, contractors, resellers, and consultants. The company was incorporated in 1998 and is headquartered in Fremont, California.

About Mirion Technologies

Mirion Technologies, Inc. provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, South Korea, and Japan. It operates through two segments, Medical and Technologies. The Medical segment offers radiation oncology quality assurance and dosimetry solutions; patient safety solutions for diagnostic imaging and radiation therapy centers; radiation therapy quality assurance solutions for calibrating and verifying imaging and treatment accuracy; and radionuclide therapy products for nuclear medicine applications, such as shielding, product handling, medical imaging furniture, and rehabilitation products. This segment supports applications in medical diagnostics, cancer treatment, practitioner safety, and rehabilitation. The Technologies segment focuses on addressing critical radiation safety, measurement, and analysis applications; and provides personal radiation detection, identification equipment, and analysis tools. The company's products and solutions also include nuclear medicines, dosimeters, contamination and clearance monitors, reactor instrumentation and control equipment and systems, medical and industrial imaging systems and related accessories, alpha spectroscopy instruments, alpha/beta counting instruments, and gamma spectroscopy detector systems; and electrical penetration, cancer diagnostics, software, and other services. It serves hospitals, clinics and urgent care facilities, dental and veterinary offices, radiation treatment facilities, OEMs for radiation therapy, laboratories, military organizations, government agencies, industrial companies, power and utility companies, reactor design firms, and NPPs. The company was formerly known as Global Monitoring Systems, Inc. and changed its name to Mirion Technologies, Inc. in January 2006. The company was incorporated in 2005 and is headquartered in Atlanta, Georgia.